PATENTS – APPLIED AND/OR GRANTED:
Single dose pharmacokinetics of Tobramycin after administration of a novel dry powder formulation (TPI) in subjects with Cystic Fibrosis (CF). Filed ~ Oct 6, 2004
Method of therapeutic administration of DHE to enable rapid relief of migraine while minimizing side effect profile. US Patents 7,994,197 B2 Issued Aug 9, 2011; US Patent 8,119,639 Issued Feb 21, 2012; US Patent 8,148,377 Issued April 3, 2012; European patent 2112/2425820 Issued March 27, 2012
Inhaled statin plus ICS in combination for atherogenic/inflammatory CAD. Filed ~ April, 2008
PK profile of inhaled DHE. Filed ~ April, 2008
Method for administering corticosteroid formulations. Filed 10 November 2008; Granted 14 May 2009 WO 2009/062193 A3
Nebulized delivery of sub-micron budesonide particles. Applied for ~ April, 2008
Inhaled delivery of TGFβ3 for treatment of IPF. Filed ~ April, 2008
Formoterol budesonide combination particles delivered via the Tempo inhaler. Filed May 15, 2009 MROI 83PROV
Intrapulmonary administration of dihydroergotamine to mammals. Filed June 26, 2009 MROI 83PROV
Inhaled Statins – Delivery methods and devices for treating inflammatory and fibrotic lung disorders. Filed May 3, 2009 MROI 006 PROV # 40,346
Final Filed April 30, 2010 MROI 006 # 12/799,737